{"id":5073,"date":"2025-09-03T10:01:16","date_gmt":"2025-09-03T08:01:16","guid":{"rendered":"https:\/\/cvja.co.za\/journal\/?p=5073"},"modified":"2026-05-05T13:21:10","modified_gmt":"2026-05-05T11:21:10","slug":"cvja-2025-039","status":"publish","type":"post","link":"https:\/\/cvja.co.za\/journal\/cvja-2025-039\/","title":{"rendered":"Is it better? Performance of the SVEAT score in predicting atherosclerotic burden in NSTE-ACS patients"},"content":{"rendered":"
\r\n
\r\n
\r\n \r\n \r\n\u00d6nder Demir\u00f6z, Muhammed Bahadir Omar, Ersin Yildirim, Kanber \u00d6cal Karabay \r\n <\/div> \r\n<\/div> \r\n
\r\n Copyright:<\/strong> Clinics Cardive Publishing (Pty) Ltd. publisher\r\n of Cardiovascular Journal of Africa.<\/div>\r\n
<\/div> \r\n
\r\n
\r\n Abstract \r\n <\/div> \r\n \r\n
\r\n \r\n \r\n \r\n \r\n Objective:<\/strong> \r\n \r\n The Symptoms, history of Vascular disease, Electrocardiography, Age, and Troponin (SVEAT) score is a novel clinical risk scoring system that is used for non- ST-elevation acute coronary syndrome (NSTE-ACS) patients. The objective of this study is to evaluate whether a relationship between SVEAT and the Synergy Between Percutaneous Coronary Intervention (SYNTAX) scores in patients who have acute coronary syndrome without ST-segment elevation is present. \r\n
\r\n \r\n Methods:<\/strong> \r\n \r\n 300 NSTE-ACS patients were enrolled in the study. SVEAT scores were calculated in an emergency room. After coronary angiography was performed for each patient, SYNTAX scores were calculated and the results compared. \r\n
\r\n\t\t\t\t\r\n\t\t\t\tResults:<\/strong> \r\n \r\n The total population was 300 patients, with a mean age of 60.35 \u00b1 12.07, 68.7% of whom were of the male sex (n =206). The median SYNTAX score of the study group was 8.00 (3.00-16.00). SVEAT scores showed a profound positive correlation with SYNTAX scores (r = 0.702, p < 0.001). An SVEAT score \u2265 5 predicted higher SYNTAX scores with 83% specificity and 73% sensitivity. Lower ejection fraction (r = -0.355, p < 0.001) and lower high-density lipoprotein (r -0.174, p = 0.004) were linked to higher SYNTAX scores. \r\n
\r\n \r\n \r\n Conclusion:<\/strong> \r\n \r\n This study is a first for the presentation of the SVEAT score as a reliable tool for estimating the SYNTAX score in NSTE-ACS patients. It will provide valuable insight to clinicians for risk stratification. \r\n
\r\n\r\n \r\n <\/div> \r\n <\/div> \r\n \r\n \r\n
\r\n \r\n Keywords:<\/strong> \r\n \r\n SVEAT score, SYNTAX score, acute coronary syndrome, coronary angiography<\/strong> \r\n \r\n <\/div> \r\n \r\n
\r\n \r\n Submitted:<\/strong> May 13, 2024; \r\n Accepted:<\/strong> March 24, 2025; \r\n Published:<\/strong> September 3, 2025
\r\n Cardiovasc J Afr 2025; 36<\/b>: 282-288<\/em>\r\n
Volume 36, Issue 3<\/strong>
\r\n <\/div> \r\n \r\n
\r\n DOI Citation Reference: dx.doi.org\/10.5830\/CVJA-2025-039 \r\n <\/div> \r\n \r\n\t\t\t\t
\r\n \r\n Sancaktepe \u015eehit Prof. Dr. \u0130lhan Varank Training and Research Hospital\r\n<\/strong>
\r\n\t\t\t\t\u00d6nder Demir\u00f6z
\r\nErsin Yildirim
\r\nKanber \u00d6cal Karabay\r\n

\r\n\r\n Lokman Hekim Hospital\r\n\r\n<\/strong>
\r\nMuhammed Bahadir Omar\r\n\r\n

\r\n \r\n\r\n [soshsc hide=\"logged\"]\r\n You need to be logged in to view and download<\/a> the full text PDF version. Register for a free account?<\/a><\/strong>

[\/soshsc]\r\n \r\n \r\n \r\n <\/div>\r\n \r\n<\/div>","protected":false},"excerpt":{"rendered":"

The Symptoms, history of Vascular disease, Electrocardiography, Age, and Troponin (SVEAT) score is a novel clinical risk scoring system that is used for non- ST-elevation acute coronary syndrome (NSTE-ACS) patients. The objective of this study is to evaluate whether a relationship between SVEAT and the Synergy Between Percutaneous Coronary Intervention (SYNTAX) scores in patients who have acute coronary syndrome without ST-segment elevation is present.<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[44,107],"tags":[],"class_list":["post-5073","post","type-post","status-publish","format-standard","hentry","category-cardiovascular-topics","category-volume-36-issue-3"],"yoast_head":"\nIs it better? Performance of the SVEAT score in predicting atherosclerotic burden in NSTE-ACS patients - Cardiovascular Journal of Africa<\/title>\n<meta name=\"description\" content=\"The Symptoms, history of Vascular disease, Electrocardiography, Age, and Troponin (SVEAT) score is a novel clinical risk scoring system that is used for non- ST-elevation acute coronary syndrome (NSTE-ACS) patients. The objective of this study is to evaluate whether a relationship between SVEAT and the Synergy Between Percutaneous Coronary Intervention (SYNTAX) scores in patients who have acute coronary syndrome without ST-segment elevation is present.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cvja.co.za\/journal\/cvja-2025-039\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Is it better? Performance of the SVEAT score in predicting atherosclerotic burden in NSTE-ACS patients - Cardiovascular Journal of Africa\" \/>\n<meta property=\"og:description\" content=\"The Symptoms, history of Vascular disease, Electrocardiography, Age, and Troponin (SVEAT) score is a novel clinical risk scoring system that is used for non- ST-elevation acute coronary syndrome (NSTE-ACS) patients. The objective of this study is to evaluate whether a relationship between SVEAT and the Synergy Between Percutaneous Coronary Intervention (SYNTAX) scores in patients who have acute coronary syndrome without ST-segment elevation is present.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cvja.co.za\/journal\/cvja-2025-039\/\" \/>\n<meta property=\"og:site_name\" content=\"Cardiovascular Journal of Africa\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-03T08:01:16+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-05T11:21:10+00:00\" \/>\n<meta name=\"author\" content=\"Jaco Moolman\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jaco Moolman\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cvja.co.za\/journal\/cvja-2025-039\/\",\"url\":\"https:\/\/cvja.co.za\/journal\/cvja-2025-039\/\",\"name\":\"Is it better? Performance of the SVEAT score in predicting atherosclerotic burden in NSTE-ACS patients - Cardiovascular Journal of Africa\",\"isPartOf\":{\"@id\":\"https:\/\/cvja.co.za\/journal\/#website\"},\"datePublished\":\"2025-09-03T08:01:16+00:00\",\"dateModified\":\"2026-05-05T11:21:10+00:00\",\"author\":{\"@id\":\"https:\/\/cvja.co.za\/journal\/#\/schema\/person\/6bf8a30a039e93fd8112db707affb920\"},\"description\":\"The Symptoms, history of Vascular disease, Electrocardiography, Age, and Troponin (SVEAT) score is a novel clinical risk scoring system that is used for non- ST-elevation acute coronary syndrome (NSTE-ACS) patients. The objective of this study is to evaluate whether a relationship between SVEAT and the Synergy Between Percutaneous Coronary Intervention (SYNTAX) scores in patients who have acute coronary syndrome without ST-segment elevation is present.\",\"breadcrumb\":{\"@id\":\"https:\/\/cvja.co.za\/journal\/cvja-2025-039\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cvja.co.za\/journal\/cvja-2025-039\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cvja.co.za\/journal\/cvja-2025-039\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cvja.co.za\/journal\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Is it better? Performance of the SVEAT score in predicting atherosclerotic burden in NSTE-ACS patients\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cvja.co.za\/journal\/#website\",\"url\":\"https:\/\/cvja.co.za\/journal\/\",\"name\":\"Cardiovascular Journal of Africa\",\"description\":\"The Cardiovascular Journal of Africa is a peer-reviewed medical journal publishing leading research in cardiovascular health across Africa since 1990\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cvja.co.za\/journal\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/cvja.co.za\/journal\/#\/schema\/person\/6bf8a30a039e93fd8112db707affb920\",\"name\":\"Jaco Moolman\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cvja.co.za\/journal\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/454c6719ed785bfd40e036ca3c3ac3347c56b4a99902df8beb62d882b1e6967f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/454c6719ed785bfd40e036ca3c3ac3347c56b4a99902df8beb62d882b1e6967f?s=96&d=mm&r=g\",\"caption\":\"Jaco Moolman\"},\"url\":\"https:\/\/cvja.co.za\/journal\/author\/jacodesignconnection-co-za\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Is it better? Performance of the SVEAT score in predicting atherosclerotic burden in NSTE-ACS patients - Cardiovascular Journal of Africa","description":"The Symptoms, history of Vascular disease, Electrocardiography, Age, and Troponin (SVEAT) score is a novel clinical risk scoring system that is used for non- ST-elevation acute coronary syndrome (NSTE-ACS) patients. The objective of this study is to evaluate whether a relationship between SVEAT and the Synergy Between Percutaneous Coronary Intervention (SYNTAX) scores in patients who have acute coronary syndrome without ST-segment elevation is present.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cvja.co.za\/journal\/cvja-2025-039\/","og_locale":"en_US","og_type":"article","og_title":"Is it better? Performance of the SVEAT score in predicting atherosclerotic burden in NSTE-ACS patients - Cardiovascular Journal of Africa","og_description":"The Symptoms, history of Vascular disease, Electrocardiography, Age, and Troponin (SVEAT) score is a novel clinical risk scoring system that is used for non- ST-elevation acute coronary syndrome (NSTE-ACS) patients. The objective of this study is to evaluate whether a relationship between SVEAT and the Synergy Between Percutaneous Coronary Intervention (SYNTAX) scores in patients who have acute coronary syndrome without ST-segment elevation is present.","og_url":"https:\/\/cvja.co.za\/journal\/cvja-2025-039\/","og_site_name":"Cardiovascular Journal of Africa","article_published_time":"2025-09-03T08:01:16+00:00","article_modified_time":"2026-05-05T11:21:10+00:00","author":"Jaco Moolman","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Jaco Moolman","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cvja.co.za\/journal\/cvja-2025-039\/","url":"https:\/\/cvja.co.za\/journal\/cvja-2025-039\/","name":"Is it better? Performance of the SVEAT score in predicting atherosclerotic burden in NSTE-ACS patients - Cardiovascular Journal of Africa","isPartOf":{"@id":"https:\/\/cvja.co.za\/journal\/#website"},"datePublished":"2025-09-03T08:01:16+00:00","dateModified":"2026-05-05T11:21:10+00:00","author":{"@id":"https:\/\/cvja.co.za\/journal\/#\/schema\/person\/6bf8a30a039e93fd8112db707affb920"},"description":"The Symptoms, history of Vascular disease, Electrocardiography, Age, and Troponin (SVEAT) score is a novel clinical risk scoring system that is used for non- ST-elevation acute coronary syndrome (NSTE-ACS) patients. The objective of this study is to evaluate whether a relationship between SVEAT and the Synergy Between Percutaneous Coronary Intervention (SYNTAX) scores in patients who have acute coronary syndrome without ST-segment elevation is present.","breadcrumb":{"@id":"https:\/\/cvja.co.za\/journal\/cvja-2025-039\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cvja.co.za\/journal\/cvja-2025-039\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/cvja.co.za\/journal\/cvja-2025-039\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cvja.co.za\/journal\/"},{"@type":"ListItem","position":2,"name":"Is it better? Performance of the SVEAT score in predicting atherosclerotic burden in NSTE-ACS patients"}]},{"@type":"WebSite","@id":"https:\/\/cvja.co.za\/journal\/#website","url":"https:\/\/cvja.co.za\/journal\/","name":"Cardiovascular Journal of Africa","description":"The Cardiovascular Journal of Africa is a peer-reviewed medical journal publishing leading research in cardiovascular health across Africa since 1990","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cvja.co.za\/journal\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/cvja.co.za\/journal\/#\/schema\/person\/6bf8a30a039e93fd8112db707affb920","name":"Jaco Moolman","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cvja.co.za\/journal\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/454c6719ed785bfd40e036ca3c3ac3347c56b4a99902df8beb62d882b1e6967f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/454c6719ed785bfd40e036ca3c3ac3347c56b4a99902df8beb62d882b1e6967f?s=96&d=mm&r=g","caption":"Jaco Moolman"},"url":"https:\/\/cvja.co.za\/journal\/author\/jacodesignconnection-co-za\/"}]}},"_links":{"self":[{"href":"https:\/\/cvja.co.za\/journal\/wp-json\/wp\/v2\/posts\/5073","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cvja.co.za\/journal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cvja.co.za\/journal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cvja.co.za\/journal\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/cvja.co.za\/journal\/wp-json\/wp\/v2\/comments?post=5073"}],"version-history":[{"count":1,"href":"https:\/\/cvja.co.za\/journal\/wp-json\/wp\/v2\/posts\/5073\/revisions"}],"predecessor-version":[{"id":5483,"href":"https:\/\/cvja.co.za\/journal\/wp-json\/wp\/v2\/posts\/5073\/revisions\/5483"}],"wp:attachment":[{"href":"https:\/\/cvja.co.za\/journal\/wp-json\/wp\/v2\/media?parent=5073"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cvja.co.za\/journal\/wp-json\/wp\/v2\/categories?post=5073"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cvja.co.za\/journal\/wp-json\/wp\/v2\/tags?post=5073"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}